Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Headline outcomes only

No studies found 0 · 0%GRADE not reported 1 · 50%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Exacerbations · participants with stable stage 2 and 3 COPD (mainly FEV1 49 ± 12% predicted), ex‐smokers (majority), smokers and non‐smokers

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Exacerbations · participants with stable stage 3 COPD, smokers and ex‐smokers with a minimum pack‐year history of 20

Beclometasone/LABA showed no clear difference in exacerbations: participants with at least one (dichotomous) compared with LABA (moderate certainty).

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
OR 0.96 [0.64, 1.45]
1 study · 465 participants
Moderate